Viewing StudyNCT06117644



Ignite Creation Date: 2024-05-06 @ 7:44 PM
Last Modification Date: 2024-10-26 @ 3:12 PM
Study NCT ID: NCT06117644
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-11-07
First Post: 2023-10-31

Brief Title: The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Organization: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Conditions & Keywords Data

Conditions:
Name
Non-small Cell Lung Cancer Stage IV
Non Small Cell Lung Cancer
EGFR Gene Mutation
Non Small Cell Lung Cancer Stage IIIA
Keywords:
Name View
Non Small Cell Lung Cancer View
EGFR Gene Mutation View
Furmonertinib View
Drug Resistance View